Select an episode
Not playing

The Next Threat: AMR, Cancer, One Health

Europe's Beating Cancer Plan boosts screening and tobacco control. A new AMR push links vets, farms, and pharmacies. Pharma reform targets shortages and innovation, while One Health readies Europe for climate-borne infections.

Episode Narrative

The European Union, a tapestry of nations stitched together by shared aspirations and tumultuous histories, stands at a crossroads in its health policy journey. Since its inception, the EU has navigated complex landscapes of public health, seeking to harmonize the varied approaches of Member States while respecting their sovereignty. The Maastricht Treaty of 1992 marked a pivotal moment, formally granting the Union a role in health policy — one that was meant to complement, not substitute, national efforts. Here began a gradual expansion of the EU’s health mandate, fostering cooperation and unity among diverse health systems.

As the years unfolded, a significant shift occurred in 2004 with the EU's “big bang” enlargement. Ten new states, largely from Central and Eastern Europe, joined the Union. This enlargement did not merely expand the geographical footprint of the EU; it transformed its health policy landscape. The introduction of these new Member States highlighted stark disparities in healthcare performance and access. Some regions flourished, while others struggled under the weight of outdated systems, remnants of the past. A mirror was held up to the EU, reflecting both the achievements and the challenges that lay ahead.

Between 2014 and 2020, the union committed nearly €80 billion to its Horizon 2020 research program, a powerful catalyst for innovation in health research. Promoting disease prevention and health promotion became paramount, particularly in the face of cross-border health threats that sought to undermine the fabric of European unity. This investment sparked a flurry of activity that emphasized the need for robust health systems. The interconnectedness of nations was further illustrated as they began to track 337 health reforms across 31 countries during the years leading up to 2025. Notably, an increasing focus on primary healthcare and care coordination emerged as a hopeful trend, reflecting a collective understanding that a more integrated system could yield better health outcomes.

Yet, the true test of this collaborative spirit came in 2020 with the unprecedented COVID-19 pandemic. The crisis peeled back the layers of complacency and illuminated the vulnerabilities within EU health systems. Suddenly, the weaknesses in crisis preparedness became glaringly apparent. The European Commission swung into action, proposing the establishment of a **European Health Union** designed to enhance health security and resilience against future threats. This initiative represented more than just a reaction; it was a call to arms, an acknowledgment that the health of one Member State impacts the health of all.

As this vision of a united health front took shape, reforms were set in motion. The European Medicines Agency and the European Centre for Disease Prevention and Control had their mandates expanded to meet the growing demands of crisis management. The establishment of the Health Emergency Preparedness and Response Authority, or HERA, represented a new dawn in how Europe would confront health threats. No longer could health security be seen as solely a national concern.

In the years that followed, from 2023 to 2025, the EU unveiled another cornerstone in its approach to health: the **Corporate Sustainability Reporting Directive**. This directive mandated climate disclosures, subtly intertwining public health with environmental well-being. It was a recognition that health is not confined to hospitals and medications; it is the air we breathe and the environment we inhabit. The complexity of health governance began to evolve, leaning towards principles of solidarity and trust, particularly foundational in this new European Health Union.

The pharmaceutical landscape, too, was undergoing profound changes. By 2024, the new regulations aimed to enhance access to oncology medicines, tackling shortages that had left many without hope. However, these reforms were not without their challenges. Concerns arose about administrative burdens and the diverse needs of national systems, revealing the ongoing debate over balancing innovation with accessibility.

Enter the **One Health** approach, a comprehensive strategy launched between 2022 and 2025, harmonizing the intricate connections between human, animal, and environmental health. This paradigm emphasized tackling antimicrobial resistance, a looming threat poised to undermine medical advancements. By integrating veterinary and agricultural sectors with healthcare, the EU sought to combat AMR decisively, acknowledging that health threats often traverse traditional boundaries.

During this transformative period, migration trends continued to shape health policy. Since 2010, the EU had faced the challenge of managing the health needs of refugees and migrants. Responses varied dramatically across Member States, underscoring the complexities of solidarity in a union comprised of diverse political and social landscapes. The uneven distribution of healthcare access remained a stark reality, revealing the necessity of not just policies, but also sincere political will.

From the 1990s through 2025, Central and Eastern European countries underwent major health system reforms, abandoning outdated Soviet-era models for more integrated, primary care-focused approaches. This shift was bolstered by EU structural funds that not only facilitated financial support but also encouraged a alignment with modern health policies. Yet, despite these advances, disparities persisted. In 2019, many citizens faced unmet healthcare needs, and a significant number were pushed into catastrophic out-of-pocket spending. This persistent inequity highlighted the ongoing struggle for universal health coverage within the EU.

Public opinion revealed another layer of complexity. Surveys in Spain reflected limited awareness of EU consular protection in health emergencies abroad, illustrating a gap in communication that warranted immediate attention. It’s clear that as much as policy frameworks are necessary, the trust and understanding of citizens profoundly impact their effectiveness.

The years 2020 to 2025 saw the EU emphasizing not just digital health literacy but also ethical handling of health data and cybersecurity. The urgency for resilience had become clearer than ever. The COVID-19 pandemic served as a painful reminder that preparation is not merely a choice; it is a responsibility. Meanwhile, support for biosimilars surged, promising cost reductions and wider access to crucial therapies across Member States.

As the landscape continued to shift, public health challenges swelled. Through the **Beating Cancer Plan**, the EU intensified its tobacco control and cancer screening programs, aiming to cut down on incidence and mortality rates through focused prevention and early detection initiatives. The road ahead appeared demanding, nascent realities underscored by the need for equitable access to care.

Navigating the next chapters of EU health policy demanded adaptability and foresight. The principles of solidarity and trust began framing a narrative that emphasized the shared responsibility among nations. As the world grappled with health disparities — starkly visible in oncology and beyond — the question lingered: how can member states maintain resilience in the face of evolving threats from AMR and cancer?

The nascent interconnectedness of health systems marks a pivotal chapter in this unfolding story, enhancing cooperation beyond borders while illuminating the roles played by various sectors in fostering public health harmonies. With challenges still looming on the horizon, the EU stands amidst a relentless storm. This journey, rich with complexities, reminds us that health is truly a shared inheritance. The legacy of the next decade will demand not just policy reform, but a commitment to the human spirit — the unwavering belief that together, societies can forge a healthier, more equitable world for generations to come.

As we look to the future, we must reflect on a powerful image: a diverse yet united Europe, standing firm against the looming specter of health threats, forging new paths through cooperation and resilience. How will history remember this chapter in the EU’s enduring quest for health? The answer, like health itself, lies in the collective actions of today.

Highlights

  • 1991-2025: The European Union (EU) progressively expanded its health mandate, starting with the Maastricht Treaty in 1992, which formally gave the EU a role in health policy focused on complementing national efforts without supplanting them, emphasizing subsidiarity and cooperation among member states.
  • 2004: The EU’s “big bang” enlargement added 10 new member states, mostly from Central and Eastern Europe, reshaping health policy collaboration and highlighting disparities in health system performance and access across the bloc.
  • 2014-2020: The EU’s Horizon 2020 research program allocated nearly €80 billion to innovation, including health research, supporting priorities such as disease prevention, health promotion, and cross-border health threats management.
  • 2018-2025: The Health System and Policy Monitor (HSPM) network tracked 337 health reforms across 31 mainly EU countries, revealing increasing interaction between primary health care and care coordination as a key trend in health system strengthening.
  • 2020: The COVID-19 pandemic exposed weaknesses in EU health systems’ crisis preparedness and coordination, prompting the European Commission to propose the creation of a European Health Union (EHU) to enhance health security, pandemic preparedness, and system resilience.
  • 2020-2025: The EHU initiative led to reforms expanding mandates of the European Medicines Agency (EMA) and the European Centre for Disease Prevention and Control (ECDC), and the establishment of the Health Emergency Preparedness and Response Authority (HERA) to coordinate responses to health threats.
  • 2023-2025: The EU implemented a new Corporate Sustainability Reporting Directive mandating climate disclosures, which indirectly supports health by addressing environmental determinants of health and enhancing market stability.
  • 2024: The EU’s pharmaceutical reforms, including the European Health Technology Assessment Regulation (HTAR) and proposed pharmaceutical legislation, aim to improve access to oncology medicines and address shortages, though concerns remain about administrative burdens and national system diversity.
  • 2022-2025: The EU launched a comprehensive One Health approach linking human, animal, and environmental health to combat antimicrobial resistance (AMR), integrating veterinary, agricultural, and pharmaceutical sectors to reduce AMR risks.
  • 2010-2025: Migration trends in the EU influenced health policy, with increased efforts to manage refugee health needs and cross-border health service access, though member states showed varying degrees of solidarity and policy implementation success.

Sources

  1. http://journal-app.uzhnu.edu.ua/article/view/328236
  2. https://www.ewadirect.com/proceedings/aemps/article/view/27659
  3. https://ibn.idsi.md/sites/default/files/imag_file/54-57_64.pdf
  4. http://economicspace.pgasa.dp.ua/article/view/335263
  5. http://visnyk-pravo.uzhnu.edu.ua/article/view/324887
  6. https://revistes.uab.cat/quadernsiee/article/view/v5-n1-biten-fernandez
  7. https://link.springer.com/10.1007/s41669-024-00556-w
  8. https://ahpsxxi.org/index.php/journal/article/view/148
  9. http://journal-app.uzhnu.edu.ua/article/view/334210
  10. https://jopir.in/index.php/journals/article/view/485